Omega-3 Fatty Acids That Affect the Immune System in Kidney Transplant Patients
NCT00047983 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 75
Last updated 2017-01-11
Summary
The purpose of this study is to evaluate the effectiveness of nutritional supplements in increasing the amount of omega-3 fatty acids (and arginine) in the red blood cell membranes and plasma of kidney transplant patients, and, secondarily, to compare patient compliance. The long-term goal of this study is to develop low risk therapies that will allow improved and lasting survival of donor tissue with minimal suppression of the immune system.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Canola oil
- DIETARY_SUPPLEMENT
-
Arginine
- DIETARY_SUPPLEMENT
-
Fish oil emulsion
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
J. W. Alexander, MD · University of Cincinnati
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 4 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Completion
- 2004-04-30
Countries
- United States
Study Locations
More Related Trials
-
Krill Oil as Supplementation to Healthy Young Adults.
NCT02053415 ·Status: COMPLETED ·Phase: NA
-
Effects of Omega-3 Fatty Acids in Ambient Air Pollution Exposure in Healthy Adults
NCT02921048 ·Status: COMPLETED
-
Effects of Omega-3 Docosapentaenoic Acid on Lipids and Other Risk Factors for Cardiovascular Disease
NCT04088240 ·Status: TERMINATED ·Phase: NA
-
Omega-3D: Omega-3 for Diet-Driven Health Disparities
NCT07078344 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of Omega-3 Fatty Acids on Acute Graft-versus-Host Disease After Allogeneic Stem Cell Transplantation.
NCT07162688 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2
-
A Phase II Randomized Trial of Fish Oil in Patients With Acute Lung Injury (ALI)
NCT00351533 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Omega-3 on Selected Cytokines Involved in Cytokine Storm
NCT04483271 ·Status: COMPLETED ·Phase: NA
-
Intervention With Omega Fatty Acids in High-risk Patients
NCT02647333 ·Status: COMPLETED ·Phase: PHASE2
-
Investigating the Effect of 4-week Omega-3 Polyunsaturated Fatty Acid Supplementation on Inflammation
NCT03210805 ·Status: UNKNOWN ·Phase: NA
-
Development of a Metabolic Assessment Tool for Chronic Kidney Disease
NCT01838239 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Acids and Cardio - Vascular Complications in Patients With Chronic Kidney Disease in Stage 1-3
NCT02147002 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Omega-3 Fatty Acids on Metabolic Syndrome
NCT00350194 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Effects of n3 LC PUFAs on Inflammatory, Immune and Senescence Features in Polyvascular Older Subjects (OMSAGE)
NCT06666101 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Omega-3 Supplementation on Serum Fetuin-A Levels
NCT05661994 ·Status: COMPLETED ·Phase: NA
-
Effects of Omega 3 in Hemodialysis Patients
NCT00431899 ·Status: COMPLETED ·Phase: NA
-
Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A Nephropathy
NCT00004448 ·Status: COMPLETED ·Phase: PHASE2
-
Omega-3 Fatty Acids and Muscle Protein Synthesis
NCT00794079 ·Status: COMPLETED ·Phase: NA
-
Effect of 12 wk of Omega-3 FA Supplementation on Metabolic and Physical Health Parameters in Older Adults
NCT01734538 ·Status: UNKNOWN ·Phase: NA
-
Dose Response Effects of Marine Omega-3 Fatty Acids on Inflammation
NCT01078909 ·Status: COMPLETED ·Phase: PHASE3
-
Potential Effects of Omega 3 Supplementation on Cardiomyocytes Membranes for Patients With Coronary Atherosclerosis?
NCT01699230 ·Status: UNKNOWN ·Phase: PHASE3
-
Immune Modulation by Parenteral Lipids
NCT00734916 ·Status: COMPLETED ·Phase: NA
-
Cardioprotective Effects of Omega-3 Fatty Acids Supplementation in Healthy Older Subjects Exposed to Air Pollution Particles
NCT01442480 ·Status: COMPLETED ·Phase: NA
-
Omega-3-Index Response to Eating Poultry Foods Naturally Enriched With Omega-3 Polyunsaturated Fatty Acids
NCT06259825 ·Status: RECRUITING ·Phase: NA
-
Omega 3 Fatty Acid Efficiency for Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting
NCT01175330 ·Status: TERMINATED ·Phase: PHASE3
-
Erythrocyte Omega-3 Fatty Acid Content in Elite Athletes
NCT02610270 ·Status: COMPLETED ·Phase: EARLY_PHASE1